Inactive
Notice ID:75D30120R67869
Amendment 00004 is hereby issued to post revisions to Section J of the solicitation document. Please review Amendment 00004 in it's entirety. Amendment 00003 is hereby issued to post revisions to sect...
Amendment 00004 is hereby issued to post revisions to Section J of the solicitation document. Please review Amendment 00004 in it's entirety. Amendment 00003 is hereby issued to post revisions to section L of the solicitation document. Please review amendment 00003 in it's entirety. Amendment 00002 is hereby issued to post revisions to the PWS and Section M of the solicitation document. Please review amendment 00002 in it's entirety. Amendment 00001 is hereby issued to post Questions and Answers and provide additional revisions to solicitation and new attachment J.12 . Please review all attachments in their entirety. The purpose of this procurement is to support clinical trials and clinical research on the treatment, diagnosis and prevention of tuberculosis (TB) throughout the ten-year performance period 2020 -2030. Emphasis will be given to studies of latent TB infection in the United States, and studies of active TB disease both domestically and internationally. See attached Solicitation for Details.